J ENDOVASC THER 润色咨询

JOURNAL OF ENDOVASCULAR THERAPY

出版年份:2000 年文章数:1544 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:22.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2023-11-27 k892050089 来自湖北省

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2022-01-18 1231910bm23(暂无昵称)

    一直都处于reviewer selectio的状态2个月的,这个是正常的吗

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2023-06-26 k892050089 来自湖北省

    审稿速度:6.0
    经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2023-05-17 ms6000001243617632 来自湖北省

    临床文章怎么做图文摘要

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2023-02-16 1741852117_36282690 来自湖北省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    我没有认识的专家,不推荐可以吗?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2021-12-27 Mia

    推荐同行评议时需要注意哪些情况?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2021-06-14 starmann

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向: 血管外科 ; 周围血管介入
    经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2017-07-18 med_wu

    过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2171261, encodeId=045d21e1261f8, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:期刊审稿速度比较慢,4月26日投稿,10月中旬才审完,期间一直是awaiting reviewer selection和awaiting reviewer assignment两个状态不断变更,总共送了三个审稿人,好在审稿人意见不错,10月19日给了大修,20日便返回了,但是25日之后才再次送给审稿人,又审了一个月,11月20日awaiting final decision,26日accept。总体来说审稿速度比较慢,如果着急发表,不建议投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Nov 27 13:26:02 CST 2023, time=2023-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1185394, encodeId=5dd3118539440, content=一直都处于reviewer selectio的状态2个月的,这个是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2383006, createdName=1231910bm23(暂无昵称), createdTime=Tue Jan 18 00:03:42 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144776, encodeId=fbc42144e76f0, content=审稿速度:6.0<br>经验分享:审稿速度非常慢,已经投稿2个月了,还没有找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=YcjibUgmdL7yibyfIF6umciaw&s=100&t=1508000380, createdBy=41e15308824, createdName=k892050089, createdTime=Mon Jun 26 10:47:27 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136481, encodeId=9001213648177, content=临床文章怎么做图文摘要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Wed May 17 11:38:21 CST 2023, time=2023-05-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114877, encodeId=c46321148e764, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中稿一篇,接收后都2个月了一直没有收到后续邮件(校对审核)等,发邮件编辑也不回,咋办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41a62428798, createdName=1741852117_36282690, createdTime=Thu Feb 16 10:19:02 CST 2023, time=2023-02-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093021, encodeId=f2f51093021a5, content=我没有认识的专家,不推荐可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093022, encodeId=cd46109302298, content=推荐同行评议时需要注意哪些情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973580, encodeId=304c9e35809b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向: 血管外科 ; 周围血管介入 <br>经验分享:二刷了谈点经验,两篇都是主动脉方向,jevt是国际介入医师协会会刊,它的编辑和审稿专家圈子是以血管和介入大咖为主的,在外周血管介入快速发展的时代,应该会迎来一波快速提升,而且近几年杂志保持了精品筛选的一贯策略,年发文数在一百多一点,审稿和修改都很严格,分值应该只增不减, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Mon Jun 14 22:38:06 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538940, encodeId=763d538940fc, content=过去不错的,现在这么跌下去,很吓人。明年想再回到3分水平,也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512056, encodeId=a3ca51205677, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。 <br> 该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。 <br> 总体来说,非常有意义的一次投稿,学习了很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f943100370, createdName=heatstones, createdTime=Sun May 24 11:11:00 CST 2015, time=2015-05-24, status=1, ipAttribution=)]
    2015-05-24 heatstones

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:不愧是介入协会的官方杂志,责编和审稿人都很好。我是2014年11月27日通过Hightail投稿(此杂志与其他杂志的在线投稿方式不同,远程共享理念),12月25日收到初审决定,按要求修回后,2015年1月22日收到接受决定,但其中一个reviewer对某个问题给了建议,再次修回后,1月27日完全接受。
    该杂志是双月刊,5月4日校稿,5月15日校准proof,将出现在8月刊上。
    总体来说,非常有意义的一次投稿,学习了很多。

    0

共18条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分